Strainsforpains Stock Performance
| EBYH Stock | USD 0.23 0.00 0.00% |
On a scale of 0 to 100, Strainsforpains holds a performance score of 3. The entity has a beta of -1.98, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Strainsforpains are expected to decrease by larger amounts. On the other hand, during market turmoil, Strainsforpains is expected to outperform it. Please check Strainsforpains' maximum drawdown, as well as the relationship between the expected short fall and day typical price , to make a quick decision on whether Strainsforpains' existing price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Strainsforpains are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Strainsforpains demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Strainsforpains |
Strainsforpains Relative Risk vs. Return Landscape
If you would invest 27.00 in Strainsforpains on September 3, 2024 and sell it today you would lose (4.00) from holding Strainsforpains or give up 14.81% of portfolio value over 90 days. Strainsforpains is currently generating 0.5292% in daily expected returns and assumes 13.2868% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Strainsforpains, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Strainsforpains Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Strainsforpains' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Strainsforpains, and traders can use it to determine the average amount a Strainsforpains' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0398
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EBYH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.29 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Strainsforpains is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Strainsforpains by adding it to a well-diversified portfolio.
Strainsforpains Fundamentals Growth
Strainsforpains Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Strainsforpains, and Strainsforpains fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Strainsforpains Pink Sheet performance.
| Current Valuation | 1.56 M | |||
| Price To Earning | (0.87) X | |||
| Cash And Equivalents | 2.29 K | |||
| Total Debt | 1.81 M | |||
| Book Value Per Share | (2.94) X | |||
| Cash Flow From Operations | (66.08 K) | |||
| Earnings Per Share | (0.23) X | |||
| Total Asset | 5.04 K | |||
| Retained Earnings | (1.38 M) | |||
| Current Asset | 35 K | |||
| Current Liabilities | 1.34 M | |||
About Strainsforpains Performance
By evaluating Strainsforpains' fundamental ratios, stakeholders can gain valuable insights into Strainsforpains' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Strainsforpains has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Strainsforpains has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Strainsforpains, Inc. operates as a medical marijuana data recommendation system. The company was incorporated in 1990 and is based in New York, New York. E-Buy Home operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about Strainsforpains performance evaluation
Checking the ongoing alerts about Strainsforpains for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Strainsforpains help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Strainsforpains is way too risky over 90 days horizon | |
| Strainsforpains has some characteristics of a very speculative penny stock | |
| Strainsforpains appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (66.08 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Strainsforpains currently holds about 2.29 K in cash with (66.08 K) of positive cash flow from operations. |
- Analyzing Strainsforpains' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Strainsforpains' stock is overvalued or undervalued compared to its peers.
- Examining Strainsforpains' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Strainsforpains' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Strainsforpains' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Strainsforpains' pink sheet. These opinions can provide insight into Strainsforpains' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Strainsforpains Pink Sheet analysis
When running Strainsforpains' price analysis, check to measure Strainsforpains' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strainsforpains is operating at the current time. Most of Strainsforpains' value examination focuses on studying past and present price action to predict the probability of Strainsforpains' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strainsforpains' price. Additionally, you may evaluate how the addition of Strainsforpains to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |